A detailed history of Moors & Cabot, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 1,805 shares of CRL stock, worth $329,665. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,805
Previous 1,995 9.52%
Holding current value
$329,665
Previous $412,000 13.83%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$187.96 - $245.29 $35,712 - $46,605
-190 Reduced 9.52%
1,805 $355,000
Q2 2024

Aug 09, 2024

BUY
$206.39 - $268.73 $3,715 - $4,837
18 Added 0.91%
1,995 $412,000
Q1 2024

May 08, 2024

SELL
$203.52 - $273.43 $60,852 - $81,755
-299 Reduced 13.14%
1,977 $535,000
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $822 - $1,194
-5 Reduced 0.22%
2,276 $538,000
Q3 2023

Nov 07, 2023

SELL
$194.44 - $217.61 $14,388 - $16,103
-74 Reduced 3.14%
2,281 $447,000
Q2 2023

Aug 09, 2023

BUY
$183.71 - $210.25 $19,840 - $22,707
108 Added 4.81%
2,355 $495,000
Q1 2023

May 04, 2023

BUY
$191.89 - $259.92 $3,454 - $4,678
18 Added 0.81%
2,247 $453,000
Q4 2022

Feb 09, 2023

BUY
$197.11 - $250.07 $84,954 - $107,780
431 Added 23.97%
2,229 $485,000
Q4 2022

Feb 06, 2023

SELL
$197.11 - $250.07 $67,214 - $85,273
-341 Reduced 15.94%
1,798 $391,000
Q3 2022

Nov 07, 2022

BUY
$182.44 - $250.54 $27,548 - $37,831
151 Added 7.6%
2,139 $421,000
Q2 2022

Aug 08, 2022

BUY
$204.13 - $302.4 $20,413 - $30,239
100 Added 5.3%
1,988 $425,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $2,555 - $3,621
-10 Reduced 0.53%
1,888 $536,000
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $35,138 - $44,868
100 Added 5.56%
1,898 $715,000
Q3 2021

Dec 08, 2021

SELL
$372.64 - $458.3 $9.61 Million - $11.8 Million
-25,798 Reduced 93.48%
1,798 $743,000
Q3 2021

Nov 05, 2021

BUY
$372.64 - $458.3 $10.3 Million - $12.6 Million
27,596 New
27,596 $610,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.29B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.